Majority shareholder tenders for Instrumentation:
This article was originally published in Clinica
Executive Summary
Private Spanish company Izasa has begun a tender offer to buy any outstanding shares in Milan, Italy-based Instrumentation Laboratory that it does not already own. Izasa owns around 59.9% of Instrumentation's shares and is offering $0.50 per share in cash. Shares in the company are currently at around that price. Instrumentation, which manufactures and distributes critical care and haemostasis in vitro diagnostics instruments and reagents, floated on Nasdaq in 1996 at $12 a share.